You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Glycosylated Hemoglobin as a Diagnostic Test for Type 2 Diabetes Mellitus
Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.
To the Editor: The article by Dr Davidson and colleagues1 strivesto bring balance to the effects of the changes in diagnosticcriteria for type 2 diabetes mellitus. Studies such as thiscan lead to further refinement in the characterization of patientsalong the spectrum of impaired glucose metabolism.
However, I noted a logical error in the article. The authorsstated that a patient with a fasting plasma glucose (FPG) concentrationof less than 7.0 mmol/L (126 mg/dL) but with a 2-hour valueof 11.1 mmol/L (200 mg/dL) or more during oral glucose tolerancetesting (OGTT) would be diagnosed as having diabetes by theold criteria but as having impaired FPG by the new criteria.This is incorrect according to the wording of the new criteriaprovided in the article. Since either an FPG concentration of7.0 mmol/L (126 mg/dL) or higher or 2-hour FPG concentrationof 11.1 mmol/L (200 . . . [Full Text of this Article]